A novel I-TAC promoter polymorphic variant is functional in the presence of replicating HCV in vitro

Journal of Clinical Virology

Volumn 32, Issue 2, 2005, Pages 137-143

  Helbig, K J ^a,b   George, J ^c   Beard, M R ^a,b  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

HCV; I TAC; Polymorphism; Promoter

Indexed keywords

CHEMOATTRACTANT; LUCIFERASE;

ARTICLE; BLOOD CULTURE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; PRIORITY JOURNAL; PROMOTER REGION; VIRUS REPLICATION;

BASE SEQUENCE; CELL LINE, TUMOR; CHEMOKINES, CXC; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); VIRUS REPLICATION;

EID: 11844273786     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.10.001     Document Type: Article

References (20)

1. R. Bellamy, and A.V. Hill Genetic susceptibility to mycobacteria and other infectious pathogens in humans Curr Opin Immunol 10 4 1998 483 487
2. R. Bonecchi, G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, and A. Borsatti Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1 1998 129 134
3. I. Clark-Lewis, I. Mattioli, J.H. Gong, and P. Loetscher Structure-function relationship between the human chemokine receptor CXCR3 and its ligands J Biol Chem 278 1 2003 289 295
4. K.E. Cole, C.A. Strick, T.J. Paradis, K.T. Ogborne, M. Loetscher, and R.P. Gladue Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 J Exp Med 187 12 1998 2009 2021
5. V. Handa, Mahboob ul h, N. Pati, U. Pati, and M. ul-Hussain Multiple liver-specific factors bind to a 64-bp element and activate apo(a) gene Biochem Biophys Res Commun 292 1 2002 243 249
6. C.E. Harvey, J.J. Post, P. Palladinetti, A.J. Freeman, R.A. Ffrench, and R.K. Kumar Expression of the chemokine IP-10 (CXCL 10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation J Leukoc Biol 74 3 2003 360 369
7. K.J. Helbig, A. Ruszkiewicz, L. Semendric, H.A. Harley, S.R. McColl, and M.R. Beard Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation Hepatology 39 5 2004 1220 1229
8. S. Hellier, A.J. Frodsham, B.J. Hennig, P. Klenerman, S. Knapp, and P. Ramaley Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection Hepatology 38 6 2003 1468 1476
9. M. Ikeda, M. Yi, K. Li, and S.M. Lemon Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells J Virol 76 6 2002 2997 3006
10. D. Kube, H. Laser, A. von Knethen, and H. Tesch The AT-rich region between -54 and -66 is important for the promoter activity of interleukin-10 in Epstein-Barr virus positive Burkitt's lymphoma cells Genes Immunol 1 2 1999 105 114
11. M. Muhlbauer, A.K. Bosserhoff, A. Hartmann, W.E. Thasler, T.S. Weiss, and H. Herfarth A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease Gastroenterology 125 4 2003 1085 1093
12. S.J. Polyak, K.S. Khabar, D.M. Paschal, H.J. Ezelle, G. Duverlie, and G.N. Barber Hepatitis C virus non-structural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response J Virol 75 13 2001 6095 6106
13. K. Promrat, and T.J. Liang Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders? Hepatology 38 6 2003 1359 1362
14. F. Sallusto, D. Lenig, C.R. Mackay, and A. Lanzavecchia Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes J Exp Med 187 6 1998 875 883
15. P.L. Shields, C.M. Morland, M. Salmon, S. Qin, S.G. Hubscher, and D.H. Adams Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver J Immunol 163 11 1999 6236 6243
16. H.M. Soo, A. Garzino-Demo, W. Hong, Y.H. Tan, Y.J. Tan, and P.Y. Goh Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES Virology 303 2 2002 253 277
17. C.P. Tensen, J. Flier, S.S. Rampersad, S. Sampat-Sardjoepersad, R.J. Scheper, and D.M. Boorsma Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene Biochim Biophys Acta 1446 1/2 1999 167 172
18. D. Theodore, and M.W. Fried Natural history and disease manifestations of hepatitis C infection Curr Top Microbiol Immunol 242 2000 43 54
19. E. Thorsby Invited anniversary review: HLA associated diseases Hum Immunol 53 1 1997 1 11
20. R.P. Woitas, G. Ahlenstiel, A. Iwan, J.K. Rockstroh, H.H. Brackmann, and B. Kupfer Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C Gastroenterology 122 7 2002 1721 1728